150 related articles for article (PubMed ID: 19321799)
21. Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice.
Zurawel RH; Allen C; Wechsler-Reya R; Scott MP; Raffel C
Genes Chromosomes Cancer; 2000 May; 28(1):77-81. PubMed ID: 10738305
[TBL] [Abstract][Full Text] [Related]
22. PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches.
Heitzer E; Bambach I; Dandachi N; Horn M; Wolf P
Exp Dermatol; 2010 Oct; 19(10):926-8. PubMed ID: 20849535
[TBL] [Abstract][Full Text] [Related]
23. MC1R and PTCH gene polymorphism in French patients with basal cell carcinomas.
Liboutet M; Portela M; Delestaing G; Vilmer C; Dupin N; Gorin I; Saiag P; Lebbé C; Kerob D; Dubertret L; Grandchamp B; Basset-Seguin N; Soufir N
J Invest Dermatol; 2006 Jul; 126(7):1510-7. PubMed ID: 16645598
[TBL] [Abstract][Full Text] [Related]
24. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts.
Zedan W; Robinson PA; Markham AF; High AS
J Pathol; 2001 Aug; 194(4):473-7. PubMed ID: 11523056
[TBL] [Abstract][Full Text] [Related]
25. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.
Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Müller U; Samson E; Quintanilla-Martinez L; Zimmer A
J Biol Chem; 2000 Sep; 275(37):28341-4. PubMed ID: 10884376
[TBL] [Abstract][Full Text] [Related]
26. PTCH codon 1315 polymorphism and risk for nonmelanoma skin cancer.
Asplund A; Gustafsson AC; Wikonkal NM; Sela A; Leffell DJ; Kidd K; Lundeberg J; Brash DE; Pontén F
Br J Dermatol; 2005 May; 152(5):868-73. PubMed ID: 15888139
[TBL] [Abstract][Full Text] [Related]
27. Role of PTCH and p53 genes in early-onset basal cell carcinoma.
Zhang H; Ping XL; Lee PK; Wu XL; Yao YJ; Zhang MJ; Silvers DN; Ratner D; Malhotra R; Peacocke M; Tsou HC
Am J Pathol; 2001 Feb; 158(2):381-5. PubMed ID: 11159175
[TBL] [Abstract][Full Text] [Related]
28. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
29. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice.
Aszterbaum M; Epstein J; Oro A; Douglas V; LeBoit PE; Scott MP; Epstein EH
Nat Med; 1999 Nov; 5(11):1285-91. PubMed ID: 10545995
[TBL] [Abstract][Full Text] [Related]
30. UV mutation signature in tumor suppressor genes involved in skin carcinogenesis in xeroderma pigmentosum patients.
D'Errico M; Calcagnile A; Canzona F; Didona B; Posteraro P; Cavalieri R; Corona R; Vorechovsky I; Nardo T; Stefanini M; Dogliotti E
Oncogene; 2000 Jan; 19(3):463-7. PubMed ID: 10656695
[TBL] [Abstract][Full Text] [Related]
31. Activating Smoothened mutations in sporadic basal-cell carcinoma.
Xie J; Murone M; Luoh SM; Ryan A; Gu Q; Zhang C; Bonifas JM; Lam CW; Hynes M; Goddard A; Rosenthal A; Epstein EH; de Sauvage FJ
Nature; 1998 Jan; 391(6662):90-2. PubMed ID: 9422511
[TBL] [Abstract][Full Text] [Related]
32. PTCH mutations: distribution and analyses.
Lindström E; Shimokawa T; Toftgård R; Zaphiropoulos PG
Hum Mutat; 2006 Mar; 27(3):215-9. PubMed ID: 16419085
[TBL] [Abstract][Full Text] [Related]
33. The sebaceous nevus: a nevus with deletions of the PTCH gene.
Xin H; Matt D; Qin JZ; Burg G; Böni R
Cancer Res; 1999 Apr; 59(8):1834-6. PubMed ID: 10213487
[TBL] [Abstract][Full Text] [Related]
34. PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: preliminary data on the influence of an exon 12-exon 23 haplotype.
Strange RC; El-Genidy N; Ramachandran S; Lovatt TJ; Fryer AA; Smith AG; Lear JT; Ichii-Jones F; Jones PW; Hoban PR
Environ Mol Mutagen; 2004; 44(5):469-76. PubMed ID: 15534865
[TBL] [Abstract][Full Text] [Related]
35. UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients.
Daya-Grosjean L; Sarasin A
Mutat Res; 2000 May; 450(1-2):193-9. PubMed ID: 10838143
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations.
Mizuno T; Tokuoka S; Kishikawa M; Nakashima E; Mabuchi K; Iwamoto KS
Carcinogenesis; 2006 Nov; 27(11):2286-94. PubMed ID: 16777989
[TBL] [Abstract][Full Text] [Related]
37. Nonmonoclonal PTCH gene mutations in psoralen plus UVA-associated basal cell carcinomas.
Heitzer E; Wolf P
J Invest Dermatol; 2008 Mar; 128(3):746-9. PubMed ID: 18059486
[No Abstract] [Full Text] [Related]
38. Immunolocalization of PTCH protein in odontogenic cysts and tumors.
Barreto DC; Bale AE; De Marco L; Gomez RS
J Dent Res; 2002 Nov; 81(11):757-60. PubMed ID: 12407090
[TBL] [Abstract][Full Text] [Related]
39. Distinctive clinical presentation of a NF-1 patient with loss of heterozygosity of PTCH in his epithelial tumors.
Jacobson E; Toms C; Huang C; Skelton H; Smith K
Int J Dermatol; 2005 Oct; 44(10):831-6. PubMed ID: 16207184
[TBL] [Abstract][Full Text] [Related]
40. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients.
Kazakov DV; Vanecek T; Zelger B; Carlson JA; Spagnolo DV; Schaller J; Nemcova J; Kacerovska D; Vazmitel M; Sangüeza M; Emberger M; Belousova I; Fernandez-Figueras MT; Kempf W; Meyer DR; Rütten A; Baltaci M; Michal M
Am J Dermatopathol; 2011 May; 33(3):251-65. PubMed ID: 21389835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
